Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyene Phosphatidylcholine in Acute Drug-Induced Liver Injury
NCT04595916Phase 4Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of polyene phosphatidylcholine in acute drug-induced liver injury (DILI), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd.. Started Apr 2020; status: completed.
02
Drugs
polyene phosphatidylcholine
03
Conditions
acute drug-induced liver injury (DILI)
Beyond the preview
Go deeper on NCT04595916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04595916.